Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: Report of an international multicenter cohort study with propensity score matching.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
05 2022
Historique:
received: 31 03 2021
revised: 09 08 2021
accepted: 12 08 2021
pubmed: 19 9 2021
medline: 3 5 2022
entrez: 18 9 2021
Statut: ppublish

Résumé

Intrahepatic cholangiocarcinoma is a rare disease with a poor prognosis. In patients where surgical resection is possible, outcome is influenced by perioperative morbidity and lymph node status. Laparoscopic liver resection is associated with improved clinical and oncological outcomes in primary and metastatic liver cancer compared with open liver resection, but evidence on intrahepatic cholangiocarcinoma is still insufficient. The primary aim of this study was to compare overall survival for a large series of patients treated for intrahepatic cholangiocarcinoma by open or laparoscopic approach. Secondary objectives were to compare disease-free survival, predictors of death, and recurrence. Patients treated with laparoscopic or open liver resection for intrahepatic cholangiocarcinoma from 2000 to 2018 from 3 large international databases were analyzed retrospectively. Each patient in the laparoscopic resection group (case) was matched with 1 open resection control (1:1 ratio), through a propensity score calculated on clinically relevant preoperative covariates. Overall and disease-free survival were compared between the matched groups. Predictors of mortality and recurrence were analyzed with Cox regression, and the Textbook Outcomes were described. During the study period, 855 patients met the inclusion criteria (open liver resection = 709, 82.9%; laparoscopic liver resection = 146, 17.1%). Two groups of 89 patients each were analyzed after propensity score matching, with no significant difference regarding pre- and postoperative variables. Overall survival at 1, 3, and 5 years was 92%, 75%, and 63% in the laparoscopic liver resection group versus 92%, 58%, and 49% in the open liver resection group (P = .0043). Adjusted Cox regression revealed severe postoperative complications (hazard ratio: 10.5, 95% confidence interval [1.01-109] P = .049) and steatosis (hazard ratio: 13.8, 95% confidence interval [1.23-154] P = .033) as predictors of death, and transfusion (hazard ratio: 19.2, 95% confidence interval [4.04-91.4] P < .001) and severe postoperative complications (hazard ratio: 4.07, 95% confidence interval [1.15-14.4] P = .030) as predictors of recurrence. The survival advantage of laparoscopic liver resection over open liver resection for intrahepatic cholangiocarcinoma is equivocal, given historical bias and missing data.

Sections du résumé

BACKGROUND
Intrahepatic cholangiocarcinoma is a rare disease with a poor prognosis. In patients where surgical resection is possible, outcome is influenced by perioperative morbidity and lymph node status. Laparoscopic liver resection is associated with improved clinical and oncological outcomes in primary and metastatic liver cancer compared with open liver resection, but evidence on intrahepatic cholangiocarcinoma is still insufficient. The primary aim of this study was to compare overall survival for a large series of patients treated for intrahepatic cholangiocarcinoma by open or laparoscopic approach. Secondary objectives were to compare disease-free survival, predictors of death, and recurrence.
METHODS
Patients treated with laparoscopic or open liver resection for intrahepatic cholangiocarcinoma from 2000 to 2018 from 3 large international databases were analyzed retrospectively. Each patient in the laparoscopic resection group (case) was matched with 1 open resection control (1:1 ratio), through a propensity score calculated on clinically relevant preoperative covariates. Overall and disease-free survival were compared between the matched groups. Predictors of mortality and recurrence were analyzed with Cox regression, and the Textbook Outcomes were described.
RESULTS
During the study period, 855 patients met the inclusion criteria (open liver resection = 709, 82.9%; laparoscopic liver resection = 146, 17.1%). Two groups of 89 patients each were analyzed after propensity score matching, with no significant difference regarding pre- and postoperative variables. Overall survival at 1, 3, and 5 years was 92%, 75%, and 63% in the laparoscopic liver resection group versus 92%, 58%, and 49% in the open liver resection group (P = .0043). Adjusted Cox regression revealed severe postoperative complications (hazard ratio: 10.5, 95% confidence interval [1.01-109] P = .049) and steatosis (hazard ratio: 13.8, 95% confidence interval [1.23-154] P = .033) as predictors of death, and transfusion (hazard ratio: 19.2, 95% confidence interval [4.04-91.4] P < .001) and severe postoperative complications (hazard ratio: 4.07, 95% confidence interval [1.15-14.4] P = .030) as predictors of recurrence.
CONCLUSION
The survival advantage of laparoscopic liver resection over open liver resection for intrahepatic cholangiocarcinoma is equivocal, given historical bias and missing data.

Identifiants

pubmed: 34535270
pii: S0039-6060(21)00785-6
doi: 10.1016/j.surg.2021.08.015
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1290-1302

Investigateurs

Julio Abba (J)
René Adam (R)
Mustapha Adham (M)
Marc-Antoine Allard (MA)
Ahmet Ayav (A)
Daniel Azoulay (D)
Philippe Bachellier (P)
Pierre Balladur (P)
Louise Barbier (L)
Julien Barbieux (J)
Emmanuel Boleslawski (E)
Karim Boudjema (K)
M Bougard (M)
Emmanuel Buc (E)
Petru Bucur (P)
Antoine Carmelo (A)
Denis Chatelain (D)
Jean Chauvat (J)
Zineb Cherkaoui (Z)
Laurence Chiche (L)
Mircea Chirica (M)
Oriana Ciacio (O)
Tatiana Codjia (T)
Fabio Colli (F)
Luciano De Carlis (L)
Jean-Robert Delpero (JR)
Nicolas Demartines (N)
Olivier Detry (O)
Marcelo Dias Sanches (MD)
Momar Diouf (M)
Alexandre Doussot (A)
Christian Ducerf (C)
Mehdi El Amrani (M)
Jacques Ewald (J)
Jean-Marc Fabre (JM)
Hervé Fagot (H)
Simone Famularo (S)
Léo Ferre (L)
Francesco Fleres (F)
Gilton Marques Fonseca (GM)
Brice Gayet (B)
Alessandro Giacomoni (A)
Jean-Francois Gigot (JF)
E Girard (E)
Nicolas Golse (N)
Emilie Gregoire (E)
Jean Hardwigsen (J)
Paulo Herman (P)
Thevi Hor (T)
François Jehaes (F)
Ali-Reza Kianmanesh (AR)
Shohei Komatsu (S)
Sophie Laroche (S)
Christophe Laurent (C)
Yves-Patrice Le Treut (YP)
K Lecolle (K)
Philippe Leourier (P)
Emilie Lermite (E)
Mikael Lesurtel (M)
Christian Letoublon (C)
Paul Leyman (P)
Jean Lubrano (J)
Jean-Yves Mabrut (JY)
Georges Mantion (G)
Ugo Marchese (U)
Riccardo Memeo (R)
Guillaume Millet (G)
Kayvan Mohkam (K)
André Mulliri (A)
Fabrice Muscari (F)
Francis Navarro (F)
Francisco Nolasco (F)
Takeo Nomi (T)
Jean Nunoz (J)
Gennaro Nuzzo (G)
Nassima Oudafal (N)
Gerard Pascal (G)
Guillaume Passot (G)
D Patrice (D)
Damiano Patrono (D)
François Paye (F)
Fabiano Perdigao (F)
Patrick Pessaux (P)
Niccolo Petrucciani (N)
Gabriella Pittau (G)
C Ratajczak (C)
Artigas Raventos (A)
Lionel Rebibo (L)
Vivian Resende (V)
Michel Rivoire (M)
Renato Romagnoli (R)
Didier Roulin (D)
Antonio Sa-Cunha (A)
Ephrem Salame (E)
Astrid Schielke (A)
Lilian Schwarz (L)
Michel Scotte (M)
François-Regis Souche (FR)
Bertrand Suc (B)
Michele Tedeschi (M)
Alexandre Thobie (A)
Boris Trechot (B)
Stéphanie Truant (S)
Olivier Turini (O)
Shinji Uemoto (S)
Xavier Unterteiner (X)
Charles Vanbrugghe (C)
Jean Zemour (J)

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Raffaele Brustia (R)

Department of Digestive and Hepato-Pancreatic-Biliary Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Créteil, France. Electronic address: https://twitter.com/raffaele.brustia.

Alexis Laurent (A)

Univ Paris Est Creteil, Faculté de Santé, Créteil, France and Department of Digestive and Hepato-Pancreatic-Biliary Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Créteil, France.

Claire Goumard (C)

Department of Hepatobiliary and Liver Transplantation Surgery, AP-HP, Hôpital Pitié Salpêtrière, CRSA, Sorbonne Université, Paris, France.

Serena Langella (S)

Department of General and Oncological Surgery, Ospedale Mauriziano, Torino, Italy.

Daniel Cherqui (D)

Centre Hepato-Biliaire, AP-HP Paul Brousse Hospital, Paris-Saclay University, Villejuif, France.

Takayuki Kawai (T)

Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Olivier Soubrane (O)

Department of Hepatobiliary Surgery, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, France.

Francois Cauchy (F)

Department of Hepatobiliary Surgery, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, France.

Olivier Farges (O)

Department of Hepatobiliary Surgery, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, France.

Benjamin Menahem (B)

Department of Digestive Surgery, University Hospital of Caen, France.

Christian Hobeika (C)

Department of Hepatobiliary and Liver Transplantation Surgery, AP-HP, Hôpital Pitié Salpêtrière, CRSA, Sorbonne Université, Paris, France.

Rami Rhaiem (R)

Department of Hepatobiliary, Pancreatic, and Digestive Surgery, Robert Debré University Hospital, Reims, France University Reims Champagne-Ardenne, France.

Daniele Sommacale (D)

Univ Paris Est Creteil, Faculté de Santé, Créteil, France and Department of Digestive and Hepato-Pancreatic-Biliary Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Créteil, France.

Shinya Okumura (S)

Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Stefan Hofmeyr (S)

Division of Surgery, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.

Alessandro Ferrero (A)

Department of General and Oncological Surgery, Ospedale Mauriziano, Torino, Italy.

François-René Pruvot (FR)

Department of Digestive Surgery and Transplantation, Univ Lille, CHRU Lille, Lille, France.

Jean-Marc Regimbeau (JM)

SSPC (Simplification of Surgical Patients Care), Clinical Research Unit, University of Picardie Jules Verne, Amiens, France and Department of Digestive Surgery, Amiens University Medical Center, Amiens, France.

David Fuks (D)

Department of Digestive, Oncologic, and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.

Eric Vibert (E)

Centre Hepato-Biliaire, AP-HP Paul Brousse Hospital, Paris-Saclay University, Villejuif, France.

Olivier Scatton (O)

Department of Hepatobiliary and Liver Transplantation Surgery, AP-HP, Hôpital Pitié Salpêtrière, CRSA, Sorbonne Université, Paris, France. Electronic address: olivier.scatton@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH